Following an Israeli study showing that the Pfizer COVID-19 vaccine is less effective against the COVID-19 Delta variant, the FDA has issued a new warning regarding side effects for the Johnson & Johnson COVID-19 vaccine. The warning has to do with the emergence of 100 cases of Guillain-Barré syndrome in vaccine recipients. J&J released a statement about the matter which can be found here.